Vistin Pharma ASA (VP4) Stock Price & Analysis

VP4 Stock Chart & Stats

€1.77€0.04(2.02%)

At close: Oct 30 1:00 AM GMT+1

Day’s Range: EUR 1.77 - EUR 1.77
52-Week Range: EUR 1.66 - EUR 2.10
Previous Close: EUR 1.74
Volume: N/A
Average Volume (3M): 0
Market Cap: EUR 79.32M
Enterprise Value: EUR 798.37M
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): N/A
Price to Earnings (P/E): 14.2
Beta: 0.34
Next Earnings: Feb 12, 2027 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: 4.81%

Vistin Pharma ASA News

Vistin Pharma Declares Additional Cash Dividend for November 2026

Vistin Pharma ASA ( ($DE:VP4) ) has provided an update. Vistin Pharma ASA has decided to distribute an additional ordinary cash dividend of NOK 0.50 per share in November, using

4d agoVP4 0RAM

Vistin Pharma Holds Volumes and Pays Extra Dividend Despite Currency Hit

Vistin Pharma ASA ( ($DE:VP4) ) has provided an announcement. Vistin Pharma ASA reported third-quarter 2026 revenue of NOK 108.4 million, essentially flat year on year in nominal terms but

4d agoVP4 0RAM

Vistin Pharma to Present Q3 and YTD 2026 Results in Investor Call

Vistin Pharma ASA ( ($DE:VP4) ) has provided an announcement. Vistin Pharma ASA announced that it will publish its third quarter and year-to-date 2026 financial results on 29 October 2026,

1w agoVP4 0RAM

Vistin Pharma Q2 Results Hit by Currency, But Sales Volume and Expansion Strengthen

An announcement from Vistin Pharma ASA ( ($DE:VP4) ) is now available. Vistin Pharma reported second-quarter 2026 revenue of MNOK 100, down from MNOK 118 a year earlier, with an

2M agoVP4 0RAM

Vistin Pharma Sets Date for Second-Quarter 2026 Results and Investor Call

Vistin Pharma ASA ( ($DE:VP4) ) just unveiled an announcement. Vistin Pharma ASA, a Norwegian producer of Metformin Hydrochloride APIs and granules for major European pharmaceutical clients, operates from Oslo

2M agoVP4 0RAM

Vistin Pharma Chair Secures Near-Majority Voting Power at AGM

Vistin Pharma ASA ( ($DE:VP4) ) has issued an announcement. Vistin Pharma ASA disclosed that its Chair of the Board, Øyvin Brøymer, has been granted open proxies representing 7,535,422 shares

5M agoVP4 0RAM

Vistin Pharma Calls Remote-Proxy Annual General Meeting for May 2026

Vistin Pharma ASA ( ($DE:VP4) ) has provided an update. Vistin Pharma ASA has called its Annual General Meeting for 20 May 2026 at 13:00 CEST, formalizing its regular governance

6M agoVP4 0RAM

Vistin Pharma Confirms 2025 Results in Published Annual Report

Vistin Pharma ASA ( ($DE:VP4) ) has issued an announcement. Vistin Pharma ASA has published its Annual Report for 2025, confirming that the final audited figures show no material changes

6M agoVP4 0RAM

Vistin Pharma Holds Steady in Q1 2026 and Proposes Higher Dividend

Vistin Pharma ASA ( ($DE:VP4) ) just unveiled an update. Vistin Pharma reported first-quarter 2026 revenue of NOK 112 million and EBITDA of NOK 27 million, with sales and earnings

6M agoVP4 0RAM

Vistin Pharma Sets Date for First-Quarter 2026 Results and Investor Call

Vistin Pharma ASA ( ($DE:VP4) ) has shared an update. Vistin Pharma ASA plans to release its first quarter 2026 results on 24 April and will host a same-day conference

6M agoVP4 0RAM

VP4 FAQ

What was Vistin Pharma ASA’s price range in the past 12 months?

Vistin Pharma ASA lowest stock price was €1.66 and its highest was €2.10 in the past 12 months.

What is Vistin Pharma ASA’s market cap?

Vistin Pharma ASA’s market cap is €79.32M.

When is Vistin Pharma ASA’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Vistin Pharma ASA’s earnings last quarter?

Vistin Pharma ASA released its earnings results on Oct 29, 2026. The company reported €0.024 earnings per share for the quarter.

Is Vistin Pharma ASA overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Vistin Pharma ASA pay dividends?

Vistin Pharma ASA does not currently pay dividends.

What is Vistin Pharma ASA’s EPS estimate?

Vistin Pharma ASA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Vistin Pharma ASA have?

Vistin Pharma ASA has 44,344,593 shares outstanding.

What happened to Vistin Pharma ASA’s price movement after its last earnings report?

Vistin Pharma ASA reported an EPS of €0.024 in its last earnings report. Following the earnings report the stock price went up 0.872%.

Which hedge fund is a major shareholder of Vistin Pharma ASA?

Currently, no hedge funds are holding shares in DE:VP4

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description